Back to 
BALYASNY ASSET MANAGEMENT L.P.
BALYASNY ASSET MANAGEMENT L.P.
FUSNShowing 0 of 2 quarters
Position history for BALYASNY ASSET MANAGEMENT L.P.'s holdings in FUSION PHARMACEUTICALS INC
As of its Q1 2024 13F, Balyasny Asset Management held 486,971 shares of FUSN (Fusion Pharmaceuticals), worth $10.4M.
Current Value
-
Current Shares
-
Total Value Change
$0
Total Shares Change
0
No position history available for this security.
Other major holders of FUSN: FEDERATED HERMES, INC., FIL Ltd, Pentwater Capital Management LP, CANADA PENSION PLAN INVESTMENT BOARD